InvestorsHub Logo
Followers 231
Posts 34993
Boards Moderated 1
Alias Born 11/19/2003

Re: Wildbilly post# 811

Monday, 08/20/2018 12:04:24 PM

Monday, August 20, 2018 12:04:24 PM

Post# of 814
Aravive FDA fast track designation pr

Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.

http://aravive.com/press-releases/u-s-fda-grants-fast-track-designation-to-aravive-biologics-avb-s6-500/